About the company
Vivani Medical Inc, a preclinical stage biopharmaceutical company, has been making groundbreaking advancements in the field of drug delivery systems. The company specializes in the development of miniaturized, subdermal implants, leveraging their proprietary NanoPortal technology. These implants offer a promising solution for the long-term, near constant-rate delivery of a wide range of medicines, specifically designed to treat chronic diseases. The unique aspect of Vivani Medical's NanoPortal technology lies in its ability to enable precise and controlled release of therapeutics over extended periods. By employing state-of-the-art nanoengineering techniques, the company has created a sophisticated portal system within these subdermal implants. Through this portal, medications can be delivered to the patient's body in a sustained and accurate manner, bypassing the need for repeated administration or invasive procedures. One of the most significant challenges in the treatment of chronic diseases is the necessity for patients to take medications regularly. Non-compliance and inconsistency in dosage often lead to suboptimal treatment outcomes. Vivani Medical aims to revolutionize this aspect of healthcare by offering a convenient, patient-friendly alternative. With their subdermal implant technology, patients can experience long-term therapy without the need for frequent dosing or complicated drug regimens. The applications of Vivani Medical's subdermal implants are vast, spanning various medical fields. These implants have the potential to treat diseases such as diabetes, cardiovascular disorders, chronic pain, autoimmune conditions, and neurological disorders, among others. By delivering therapeutics directly to the site of action or the systemic circulation, Vivani Medical's implants offer a highly targeted and efficient mode of drug delivery, enhancing the efficacy and safety of treatment options for these conditions. The NanoPortal technology also holds great promise for personalized medicine. By customizing the release rates and dosages of medications according to individual patient needs, Vivani Medical's implants can optimize treatment outcomes while minimizing side effects. This personalized approach allows for tailored therapies, ultimately improving patients' quality of life and reducing the burden of managing chronic diseases. Furthermore, the miniaturization of these implants ensures their discreet and unobtrusive nature, providing patients with a sense of normalcy and independence. Unlike traditional drug delivery methods, patients using Vivani Medical's implants can continue with their daily routines without interruption, avoiding the stigma often associated with visible medical devices. This aspect of patient experience is crucial in promoting adherence to treatment and improving overall well-being. As a preclinical stage company, Vivani Medical is currently conducting extensive research and development to refine and validate the efficacy and safety of its subdermal implant technology. The company is collaborating with leading experts in the fields of bioengineering, nanotechnology, and medicine to advance the understanding of drug delivery systems and to optimize the design and functionality of their NanoPortal technology. Through strategic partnerships and ongoing clinical trials, Vivani Medical aims to bring their innovative subdermal implants to market in the near future. The company's vision is to revolutionize the treatment landscape for chronic diseases, enhancing patients' lives and transforming the way medications are delivered. With their cutting-edge NanoPortal technology, Vivani Medical is poised to make a substantial impact on global healthcare, offering a new era of personalized, long-term drug delivery solutions.
Website: https://www.vivani.com
Data updated: June 2, 2026
